Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents.


BACKGROUND Immunotherapy with anti-IgE antibodies for treatment of allergy is promising but a short half-life and extremely high cost limit its application. OBJECTIVE We sought to develop IgE vaccines that induce longer-lasting auto-antibodies to neutralize self-IgE as an alternative therapy. METHODS The vaccine was made by conjugating three synthetic… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.